Guidance and quality standards In consultation
Showing 1 to 3 of 3
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A [ID6170] | Draft guidance | Technology appraisal guidance | |
Danicopan as an add-on treatment to a C5 inhibitor for treating extravascular haemolysis in adults with paroxysmal nocturnal haemoglobinuria [ID5088] | Draft guidance | Technology appraisal guidance | |
Tirzepatide for managing overweight and obesity [ID6179] | Draft guidance | Technology appraisal guidance |